SCHEMBL5248809

SCHEMBL5248809

CNCCCOC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5246035 0.93 CHRM2 (0.43)
SCHEMBL5245054 0.92 CHRM2 (0.39)
SCHEMBL6289595 0.91 EPHX1 (0.42)
SCHEMBL5247896 0.86
Hydrochloric Acid SCHEMBL21066073 0.84
SCHEMBL16845049 0.79
SCHEMBL5953478 0.79
SCHEMBL20749780 0.78 HTR2C (0.41)
SCHEMBL31181399 0.78 TSHR (0.42)
SCHEMBL5246963 0.78 TSHR (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117164481-A Methyl (3-methylaminopropyl) carbamate derivatives of ZL006-05 and pharmaceutically acceptable salts thereof and pharmaceutical application thereof 苏州南医大创新中心 2023-12-05 CN claimed
CN-117586160-A Sulfur-containing prodrug compound and medical application thereof 中国药科大学 2024-02-23 CN disclosed
CN-117164481-A Methyl (3-methylaminopropyl) carbamate derivatives of ZL006-05 and pharmaceutically acceptable salts thereof and pharmaceutical application thereof 苏州南医大创新中心 2023-12-05 CN disclosed
CN-117164481-A Methyl (3-methylaminopropyl) carbamate derivatives of ZL006-05 and pharmaceutically acceptable salts thereof and pharmaceutical application thereof 苏州南医大创新中心 2023-12-05 CN disclosed
CN-117164481-A Methyl (3-methylaminopropyl) carbamate derivatives of ZL006-05 and pharmaceutically acceptable salts thereof and pharmaceutical application thereof 苏州南医大创新中心 2023-12-05 CN disclosed
CN-116903588-A Five-membered and six-membered compound, intermediate, preparation method, composition and application 厦门市博瑞来医药科技有限公司 2023-10-20 CN disclosed
CN-116693411-A Novel carbonyl lipid and lipid nanoparticle formulations for delivery of nucleic acids 爱康泰生治疗公司 2023-09-05 CN disclosed
CN-116368131-A Novel Smad3 protein degradation agent and application thereof 和径医药科技(上海)有限公司 2023-06-30 CN disclosed
CN-110799492-B Novel carbonyl lipid and lipid nanoparticle formulations for delivery of nucleic acids 爱康泰生治疗公司 2023-06-27 CN disclosed
CN-116284089-A Fluoboric part cyanine fluorescent probe and preparation method and application thereof 四川大学华西医院 2023-06-23 CN disclosed
CN-114258318-A Aminopyrimidine amide autophagy inhibitors and methods of use thereof 德西费拉制药有限责任公司 2022-03-29 CN disclosed
WO-2021158707-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2021-08-12 WO disclosed
CN-108349963-B Sodium channel blockers 株式会社大熊制药 2021-03-30 CN disclosed
CN-107205961-B Prodrugs of phenolic TRPV1 agonists 同心镇痛药物公司 2021-03-16 CN disclosed
WO-2020120576-A1 p38α AUTOPHOSPHORYLATION INHIBITORS FUNDACIÓ INSTITUT DE RECERCA BIOMÈDICA (IRB BARCELONA) (ES) 2020-06-18 WO disclosed
CN-110799492-A Novel carbonyl lipid and lipid nanoparticle formulations for delivery of nucleic acids 爱康泰生治疗公司 2020-02-14 CN disclosed
CN-108349963-A sodium channel blockers 株式会社大熊制药 2018-07-31 CN disclosed
EP-1379598-B1 UNSATURATED COMPOUNDS CONTAINING CARBAMATE TERMINAL GROUPS OR UREA TERMINAL GROUPS BASF AG (DE) 2007-09-12 EP disclosed
US-6916854-B2 Heat and/or light curable films or coatings comprising polyurethanes or polyureaurethane copolymers having storage stability, used as automobile paints BASF AKTIENGESELLSCHAFT (DE) 2005-07-12 US disclosed
US-20040097642-A1 Unsaturated compounds containing carbamate terminal groups or urea terminal groups BASF AKTIENGESELLSCHAFT (DE) 2004-05-20 US disclosed